Mangalam Drugs & Organics Limited Stock NSE India S.E.
Equities
MANGALAM
INE584F01014
Pharmaceuticals
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
109.6 INR | +1.17% | -2.22% | +12.07% |
Sales 2022 | 4.48B 53.56M | Sales 2023 | 3.7B 44.3M | Capitalization | 1.55B 18.54M |
---|---|---|---|---|---|
Net income 2022 | 197M 2.36M | Net income 2023 | 12M 144K | EV / Sales 2022 | 0.56 x |
Net Debt 2022 | 859M 10.29M | Net Debt 2023 | 859M 10.28M | EV / Sales 2023 | 0.65 x |
P/E ratio 2022 |
8.28
x | P/E ratio 2023 |
122
x | Employees | 523 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 45.3% |
1 day | +1.51% | ||
1 week | -2.22% | ||
Current month | +6.23% | ||
1 month | -2.73% | ||
3 months | +10.06% | ||
6 months | +5.52% | ||
Current year | +12.07% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 70 | 96-04-15 | |
Ajay A. Samant
DFI | Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 70 | 96-04-15 | |
Praveen Saxena
BRD | Director/Board Member | 69 | 21-03-20 |
Director/Board Member | 73 | 15-02-04 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-16 | 109.6 | +1.17% | 3 617 |
24-07-15 | 108.4 | +1.66% | 29,827 |
24-07-12 | 106.6 | -2.99% | 40,882 |
24-07-11 | 109.9 | -0.46% | 41,901 |
24-07-10 | 110.4 | -1.88% | 39,218 |
Delayed Quote NSE India S.E., July 16, 2024 at 12:29 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+26.40% | 45.54B | |
+34.45% | 24.51B | |
+26.79% | 16.48B | |
+22.00% | 14.66B | |
+72.92% | 14.3B | |
-0.05% | 6.79B | |
-11.41% | 6.73B | |
+18.15% | 5.87B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- MANGALAM Stock
- MANGALAM Stock